EUVIMEDEUVIMED entdecken
Crossref

The impact of TRPV4 pathogenic mutations on barrier integrity

Gabriela Sampaio iD, Taylor Ismaili, Ali Torkamani, David G Breckenridge, Ashley Katana, David B Goldstein, Sunil Sahdeo

Human Molecular Genetics · 2025

DOI: 10.1093/hmg/ddaf023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Molecular Genetics, 2025. Verfasst von Gabriela Sampaio und 6 weiteren Autor:innen. Beteiligte Einrichtung: Actio Biosciences, 11202 El Camino Real, Suite 100, San Diego, California, 92130, United States of America. Hauptthemen laut MEDLINE: TRPV Cation Channels, Mutation, Peripheral Nervous System Diseases, Osteochondrodysplasias. Die Arbeit nennt 26 Literaturangaben. Gefördert von: Actio Biosciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pathogenic mutations in the Transient Receptor Potential Vanilloid 4 (TRPV4) gene cause two classes of rare autosomal dominant disorders: peripheral neuropathies and skeletal dysplasias. Although most TRPV4 pathogenic mutations increase ion flux, it remains unclear how different mutations in TRPV4 cause such distinct disease presentations. Through an in vitro cell impedance platform, we showed that TRPV4 overactivity leads to cell barrier disruption, while pharmacological or genetic inhibition of TRPV4 activity protects against barrier disruption. Unexpectedly, we find that mutations causing peripheral neuropathies and metatropic dysplasias are more likely to cause barrier disruption than mutations causing non-metatropic skeletal dysplasia presentations. Finally, we show that a novel TRPV4 inhibitor (ABS-0872) protects cell-barrier disruption and promotes recovery of barrier integrity after damage caused by TRPV4 mutations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TRPV Cation ChannelsMutationPeripheral Nervous System DiseasesOsteochondrodysplasiasHumansAnimalsMice

Stichwörter der Autor:innen

Barrier integrityCMT2CCell BarrierTRPV4

Substanzen

TRPV Cation ChannelsTRPV4 protein, human

Autor:innen und Institutionen

  • Actio Biosciences, 11202 El Camino Real, Suite 100, San Diego, California, 92130, United States of America.

ORCID-Profile: Gabriela Sampaio

Förderung

  • Actio Biosciences

Zitieren

APA

Sampaio, G., Ismaili, T., Torkamani, A., Breckenridge, D. G., Katana, A., Goldstein, D. B., & Sahdeo, S. (2025). The impact of TRPV4 pathogenic mutations on barrier integrity. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddaf023

Vancouver

Sampaio G, Ismaili T, Torkamani A, Breckenridge DG, Katana A, Goldstein DB, et al. The impact of TRPV4 pathogenic mutations on barrier integrity. Human Molecular Genetics. 2025. doi:10.1093/hmg/ddaf023

BibTeX
@article{Sampaio2025,
  author = {Sampaio, Gabriela and Ismaili, Taylor and Torkamani, Ali and Breckenridge, David G and Katana, Ashley and Goldstein, David B and Sahdeo, Sunil},
  title = {The impact of TRPV4 pathogenic mutations on barrier integrity},
  journal = {Human Molecular Genetics},
  year = {2025},
  doi = {10.1093/hmg/ddaf023}
}
Kostenlos starten →